We are seeking 2x Scientists with research experience in organic synthesis and/or medicinal chemistry to join an industry-academia, multi-disciplinary drug discovery team based in the new Centre for Targeted Protein Degradation (CeTPD) within Dundee’s School of Life Sciences.
The team is engaged in a major and expanding collaboration on proteolysis-targeting chimeras (PROTAC) drug discovery between the laboratories of Professor Alessio Ciulli (http://www.lifesci.dundee.ac.uk/groups/alessio-ciulli) and Boehringer Ingelheim. Our mission is to discover novel small-molecule degraders to treat cancer. The scientist will boost the structure guided medicinal chemistry approaches the team are taking to accelerate translation of research in this field and to develop degrader drug candidates.
This is a unique opportunity to gain experience in world-leading industry-style drug discovery within an academic setting. The posts may also provide opportunities for short work placements at Boehringer Ingelheim’s research site.
The positions are available until 31st December 2023 in the first instance and are available to start immediately.
Your priorities will include:
Appointment on the Grade 7 salary scale is dependent upon you having been awarded a PhD. An appointment may be considered if you are shortly expected to be awarded a PhD. In this case the initial appointment would be made as a Research Assistant on the Training Grade 7 salary scale (Spinal Point 25 – 28).
Commitment to DORA
The School of Life Sciences has been fully committed to the principals of the San Francisco Declaration on Research Assessment (DORA) since 2013. In assessing applicants, we consider the scientific quality of their published research papers, but do not take into account where the papers were published and do not consider journal-based metrics, such as Journal Impact Factors.
Informal enquiries may be made to Professor Alessio Ciulli, e-mail: email@example.com
About the Centre for Targeted Protein Degradation (CeTPD)
Within the University of Dundee, the newly announced Centre for Targeted Protein Degradation (CeTPD) due to open in mid 2022 is being created as a first of its kind Centre leading a number of internationally significant projects. The goal of CeTPD is to innovate the next-generation of small-molecule platforms and modalities to advance chemical and biological insights and therapeutic targets related to human diseases. It aspires to achieve this by openly collaborating with academic, industrial and venture partners, and by inspiring the next-generation of research scientists and leaders.
The University of Dundee main city-centre campus is at the heart of Dundee - an up-and-coming, friendly, compact and affordable city.
Family friendly policies, staff support networks for BME and LGBT staff, membership of Athena Swan and Stonewall, as well a full range of disability services, create an enjoyable and inclusive place to work.
Medicinal/Organic Chemistry Scientist (x2), UoD-Boehringer Ingelheim PROTAC drug discovery.
Centre for Targeted Protein Degradation
Monday, June 27, 2022
£33,309 - £40,927